Mechanisms and clinical implications of endothelium-dependent vasomotor dysfunction in coronary microvasculature

Area of Science:

• Cardiovascular Medicine
• Vascular Biology
• Metabolic Syndrome Research

Background:

• Coronary microvascular disease (CMD) is a significant cause of morbidity and mortality, particularly in patients with metabolic syndrome.
• Endothelial dysfunction in coronary arterioles and capillaries leads to impaired myocardial perfusion and reduced coronary flow reserve.
• CMD is an independent risk factor for cardiac death, even without obstructive coronary artery disease.

Purpose of the Study:

• To review normal coronary microvascular physiology and methods for assessing microvascular function.
• To discuss the clinical implications and diagnostic challenges of CMD.
• To explore the molecular mechanisms underlying endothelial injury and vasomotor dysfunction in CMD.

Main Methods:

• Literature review of normal coronary microvascular physiology.
• Overview of techniques for measuring coronary microvascular function.
• Synthesis of current research on molecular mechanisms of CMD.

Main Results:

• Metabolic syndrome components (diabetes, hypertension, hyperlipidemia, obesity) contribute to endothelial injury and arteriolar dysfunction.
• Dysregulated coronary endothelial homeostasis results from inflammation, oxidative stress, insulin resistance, and other factors.
• Diminished coronary flow reserve is a key clinical manifestation of CMD.

Conclusions:

• CMD significantly impacts cardiac health, necessitating a deeper understanding of its pathophysiology.
• Identifying molecular mechanisms of endothelial dysfunction is crucial for developing targeted therapies.
• Further research into CMD is vital for reducing cardiovascular mortality and morbidity.